本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bicycle Therapeutics Limited

8.23
+0.00710.09%
成交量:28.19万
成交额:236.94万
市值:5.70亿
市盈率:-2.35
高:8.75
开:8.21
低:8.06
收:8.22
52周最高:25.39
52周最低:6.10
股本:6,930.65万
流通股本:307.84万
量比:1.28
换手率:9.16%
股息:- -
股息率:- -
每股收益(TTM):-3.5033
每股收益(LYR):-2.9039
净资产收益率:-31.42%
总资产收益率:-19.07%
市净率:0.85
市盈率(LYR):-2.83

数据加载中...

公司资料

公司名字:
Bicycle Therapeutics Limited
交易所:
NASDAQ
成立时间:
2009
员工人数:
305
公司地址:
Portway Building,Blocks A & B,Granta Park,Great Abington,Cambridge,Cambridgeshire,United Kingdom
邮编:
CB21 6GS
传真:
- -
简介:
Bicycle Therapeutics plc于2017年10月27日根据英格兰和威尔士法律注册成立。该公司是一家临床阶段的生物制药公司,开发一种新型药物,他们称之为自行车,用于现有治疗方法不足的疾病。自行车是完全合成的短肽,限制形成两个环,稳定它们的结构几何形状。该约束旨在赋予高亲和力和选择性,并且由分子呈现的相对大的表面积允许靶向药物,其历史上对于非生物学方法是难以处理的。自行车是一种独特的治疗方式,将通常与生物制剂相关的药理学与小分子的制造和药代动力学或PK特性相结合。

董事

名称
职位
Felix J. Baker
Chairman of the Board
Kevin Lee
Director and Chief Executive Officer
Alessandro Riva
Independent Director
Greg Winter
Independent Director
Janice Bourque
Independent Director
Jose Carlos Gutierrez Ramos
Independent Director
Stephen Sands
Independent Director
Charles Swanton
Director
Fabrice Andre
Director
Hervé Hoppenot
Director
Roger Danse
Director

股东

名称
职位
Kevin Lee
Director and Chief Executive Officer
Alistair Milnes
Chief Operating Officer
Alethia Young
Chief Financial Officer
Jim MacDonald Clink
Senior Vice President and Head of Business Development
Eric Westin
Chief Medical Officer
Michael Charles Ferguson Hannay
Chief Product Officer and Chief Supply Chain Officer
Michael Skynner
Chief Technology Officer
Travis Thompson
Chief Accounting Officer